European Journal of Translational and Clinical Medicine

Expand

Journal Policy


Authorship and contributorship

Authorship should be limited only to those people who have made a significant contribution to the submitted work, specifically: research concept and design, data collection and/or organization, data analysis and interpretation, writing the manuscript, critical revision of the manuscript, final approval of the manuscript. Likewise, it is unethical for authors to omit from the author list a person/s who contributed to the above-listed tasks (that is the so-called “ghost authorship”).
Furthermore, guest authorship (also referred to as “gift authorship”) is not allowed.
The Acknowledgements section is the appropriate place to list the names of all people who do not meet the criteria of significant contribution.

During the submission process, the authors are required to list all authors and mark their contribution to the submitted manuscript. During the initial screening process, the Vice-Editor-in-Chief reviews this information. In case of doubt, the Vice-Editor-in-Chief directly contacts the corresponding author, investigates the issue and requests appropriate changes to the author list and/or contributions.

All requests to add or remove authors from the author list before or during publishing the article in the EJTCM shall be handled by the Vice-Editor-in-Chief by contacting all the remaining authors (if possible) and obtaining their permission for the addition or removal of any authors.
All equivocal cases shall be resolved in accordance with the COPE guidelines https://publicationethics.org/resources/guidelines.


Originality and plagiarism

The authors must ensure that they are submitting an entirely original work. If the methods, data, graphics and/or words from other published articles have been used in the manuscript, this must be appropriately cited or quoted.
An author may not publish manuscripts describing essentially the same research in more than one journal or primary publication. EJTCM does not consider the following uses of a work as prior publication: publication in the form of an abstract, publication as an academic thesis or dissertation, publication as an electronic preprint.

During the submission process, the authors are required to mark whether or not their submitted work has been copyrighted or published elsewhere. In addition, the corresponding author is required to send a signed copy of the EJTCM Author Agreement to the EJTCM Editorial Office.
During the initial screening process all submitted manuscripts are verified against plagiarism using the iThenticate service. Each report from iThenticate is analyzed for the extent of severity of the plagiarism on a case-by-case basis by the Language Editor and the Vice-Editor-in-Chief. The Editorial Team makes a decision to either:

  • contact the corresponding author about the plagiarism and rejection of the manuscript,
  • or to contact the corresponding author with request to revise the appropriated portion of the manuscript. In case of no response or the corresponding author’s lack of cooperation, all of the remaining authors shall be contacted with the same request. In case of no response, the manuscript shall be on hold while the authors’ respective superiors/institutions are contacted.
All equivocal cases shall be resolved in accordance with the COPE guidelines.


Conflicts of interest and sources of research funding

All authors are required to disclose potential conflicts of interest relevant to the subject of their manuscript at the time of submission. Regardless if conflicts of interest exist or not, the authors must mention that in the Acknowledgements section.

Authors are required to identify sources of financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s) in: study design, data collection, analysis or interpretation, writing of the manuscript and in the decision to submit it for publication. If the funding source(s) had no such involvement, then this should also be stated. Include a statement describing the funding source in the Acknowledgments section.

All communication and/or evidence submitted to the EJTCM Editorial Office about the author/s’ undisclosed conflicts of interest shall be treated seriously and promptly investigated by either the Editor-in-Chief or the Vice-Editor-in-Chief and handled in accordance with the COPE guidelines.


Acknowledgements section

Authors are required to identify sources of financial support for the research described in the manuscript and/or preparation of the manuscript. Please briefly describe the role of the sponsor(s) in: research design, data collection, analysis or interpretation, writing of the manuscript and in the decision to submit it for publication. If the funding source(s) had no such involvement, then this should also be stated.


Ethical oversight

Statements of compliance are required if the work involves chemicals, procedures or equipment that has any unusual hazards inherent in their use, or if it involves the use of animal or human subjects.
Studies on patients or volunteers require their consent as well as an approval of the local ethics committee. Both should be documented in the Acknowledgements section.

Manuscripts describing research that required ethical approval but lacking a clear statement about it shall not be considered for review and publish by the EJTCM.


Post-publication discussions and corrections

Authors may be asked to provide the raw data in connection with an article for editorial review, and should be prepared to provide public access to such data.
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author's obligation to promptly notify the EJTCM Editorial Office and cooperate with the EJTCM Editorial Team to retract or correct the paper.


Complaints, allegations of academic (research) misconduct and appeals

All communication and/or evidence submitted to the EJTCM Editorial Office about the author/s’ alleged academic (research) misconduct shall be treated seriously and promptly investigated by either the Editor-in-Chief or the Vice-Editor-in-Chief and handled in accordance with the COPE guidelines.
All appeals shall be handled by the EJTCM Editorial Team in accordance with the COPE guidelines.


Journal funding sources

The European Journal of Translational and Clinical Medicine is owned and funded by its publisher, the Medical University of Gdańsk, a public, tax payer-funded university.
EJTCM does not collect any fees from article authors.
EJTCM is open for cooperation with biomedical societies, biomedical conference organizers, biomedical and pharmaceutical industry regarding reprints and commercial distribution of EJTCM articles. Such requests are reviewed by the EJTCM Editorial Team on a case-by-case basis. These for-profit activities are undertaken for the sole purpose of funding the EJTCM budget and cover the costs of publisher association memberships, software license renewal and other expenses necessary for the functioning of the Journal.